These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2165 related articles for article (PubMed ID: 33950730)

  • 1. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health.
    Zuckerman DM
    Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergency Use Authorizations of COVID-19-Related Medical Products.
    Moshkovits I; Shepshelovich D
    JAMA Intern Med; 2022 Feb; 182(2):228-229. PubMed ID: 34928303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2021 FDA approvals: value driven by COVID-19 vaccines.
    Baedeker M; Ringel MS; Schulze U
    Nat Rev Drug Discov; 2022 Feb; 21(2):90. PubMed ID: 35039671
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA authorizes Johnson & Johnson COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    Sharfstein JM; Goodman JL; Borio L
    JAMA; 2021 Mar; 325(12):1153-1154. PubMed ID: 33587124
    [No Abstract]   [Full Text] [Related]  

  • 7. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
    Mbaeyi S; Oliver SE; Collins JP; Godfrey M; Goswami ND; Hadler SC; Jones J; Moline H; Moulia D; Reddy S; Schmit K; Wallace M; Chamberland M; Campos-Outcalt D; Morgan RL; Bell BP; Brooks O; Kotton C; Talbot HK; Lee G; Daley MF; Dooling K
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1545-1552. PubMed ID: 34735422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.
    Bhimraj A; Morgan RL; Shumaker AH; Lavergne V; Baden L; Cheng VC; Edwards KM; Gandhi RT; Gallagher JC; Muller WJ; O'Horo JC; Shoham S; Wollins DS; Falck-Ytter Y
    Clin Infect Dis; 2022 May; 74(9):1686-1690. PubMed ID: 34668010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
    Kesselheim AS; Darrow JJ; Kulldorff M; Brown BL; Mitra-Majumdar M; Lee CC; Moneer O; Avorn J
    Health Aff (Millwood); 2021 Jan; 40(1):25-32. PubMed ID: 33211535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):145-146. PubMed ID: 34550960
    [No Abstract]   [Full Text] [Related]  

  • 11. The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.
    Tran A; Witek TJ
    Pharmaceut Med; 2021 Jul; 35(4):203-213. PubMed ID: 34453703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Dal-Ré R
    Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2022 Jan; 64(1642):16. PubMed ID: 35134045
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion: The FDA is Unprepared for Personalized Medicine.
    Tabarrok A
    Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA authorizes Moderna COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
    Bellino S
    Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    Thomson K; Nachlis H
    JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA authorizes first single-shot COVID-19 vaccine.
    Mullard A
    Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996
    [No Abstract]   [Full Text] [Related]  

  • 20. Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(13):e54. PubMed ID: 34551238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 109.